Johnson & Johnson Baby Powder Cancer Lawsuit

Johnson & Johnson faces New UK Lawsuit Over Talc-Cancer Link

A new class-action lawsuit has been filed in the united Kingdom against pharmaceutical giant Johnson & Johnson,adding to existing legal battles in the United States concerning allegations that its talc products contained asbestos and caused various forms of cancer.

The complaint, filed before the High Court in London on Thursday, represents over 3,000 plaintiffs and seeks compensation possibly exceeding £1 billion (approximately $1.15 billion euros). According to the law firm KP Law, the suit alleges that Johnson & Johnson knowingly sold talc products containing carcinogenic fibers for more than 50 years, despite internal awareness of the risks.

Decades of Allegations

The legal action details claims spanning from 1965 to 2023, asserting that Johnson & johnson was aware its talc products contained carcinogenic fibers, including asbestos, yet continued to market them. Plaintiffs allege they developed cancers of the pleura, peritoneum, and ovaries after using the products. The products were withdrawn from the British market in 2023, three years after being removed from shelves in the United States and Canada.

“This claim details how Johnson & Johnson knew that its talc products contained carcinogenic fibers,including asbestos,for more than fifty years and chose to keep them on the market,” a statement from KP Law reads.

Did you know? – Talc is a naturally occurring mineral composed of magnesium, silicon, and oxygen. It’s valued for its softness and ability to absorb moisture, leading to its use in many consumer products.

Corporate Restructuring and Liability

Johnson & Johnson, contacted by AFP, maintains that its former consumer health division, now operating as Kenvue since 2023, is responsible for “any presumed liability relating to talc-related litigation outside the United States and Canada.”

A Kenvue spokesperson stated that “years of testing by autonomous and renowned laboratories, universities and health authorities in the UK and around the world” confirm the product’s safety, asserting it “does not contain asbestos and does not cause cancer.”

Pro tip: – Product liability lawsuits frequently enough hinge on demonstrating a company’s knowledge of a product’s potential harm and a failure to warn consumers. Internal documents are key evidence.

Previous Settlement Attempts and WHO Classification

In April, the American justice system rejected a proposed settlement from Johnson & Johnson, wich offered to pay approximately $8 billion over 25 years to resolve 90,000 civil complaints in the U.S. linked to ovarian problems – representing 99.75% of current complaints. The offer was made without acknowledging obligation for the alleged harm.

Adding to the scrutiny, the World Health Organization’s (WHO) cancer agency classified talc as “probably carcinogenic” in July 2024. However,a January 2020 summary of studies involving 250,000 women in the United States found no statistically meaningful link between genital talc use and ovarian cancer risk.

The ongoing legal challenges and evolving scientific understanding of talc’s potential health risks underscore the complexities of product liability and the long-term consequences of corporate decisions.

Reader question: – How should consumers weigh conflicting scientific studies when making decisions about product safety? what role does corporate funding play in research?

Here’s a substantive news report answering the “why, who, What, and How” questions:

Why: A new class-action lawsuit alleges that Johnson & Johnson knowingly sold talc products containing asbestos and other carcinogenic fibers for over 50 years, despite internal awareness of the risks. Plaintiffs claim these products caused them to develop various cancers.

Who: The lawsuit, filed in the UK

Worth a look

• Discharge Petitions, Explained: The Tool Surging Past Mike Johnson (daybreakwire.com)